Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...